Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Nashville | 10,806 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,806 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1481-1500 of 10,806 trials

TerminatedOpen-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)The study will assess safety and tolerability of 0.5 mg/day and 1 mg/day of sublingual (under the tongue) formulation of agomelatine (AGO178) in patients with Major Depressive…NCT01156415·Birmingham, Alabama and 97 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedEvaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)To evaluate the safety and tolerability of pamrevlumab in participants with IPF, and the efficacy of pamrevlumab in slowing the loss of forced vital capacity (FVC) and the…NCT01890265·Birmingham, Alabama and 41 others

UnknownAngiogenesis in Women With Angina Pectoris Who Are Not Candidates for RevascularizationThe purpose of this study is to determine whether a one-time intracoronary infusion of Ad5FGF-4 is effective in reducing the time to onset myocardial ischemia as measured by…NCT00438867·Birmingham, Alabama and 46 others

Active not recruitingACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve ReplacementTo evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic…NCT03735667·Birmingham, Alabama and 74 others

Approved for marketingExpanded Access Study of TAS-102 in Patients With Metastatic Colorectal CancerThe objective of the program is to provide access to TAS-102 to patients with metastatic colorectal cancer who are refractory to or failing standard chemotherapy, are new to…NCT02286492·Birmingham, Alabama and 32 others

CompletedTrial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)The purpose of this study is to find out whether Nivolumab will significantly improve overall survival as compared to therapy of investigator's choice in patients with recurrent…NCT02105636·Stanford, California and 63 others

CompletedA Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy RegimenThe purpose of this study is to estimate the incidence and characterize the outcome of high grade, select adverse events in subjects with advanced or metastatic NSCLC treated with…NCT02066636·Mobile, Alabama and 133 others

CompletedA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)This is a randomized, multicenter, open-label, two-arm, Phase II study to evaluate the efficacy, safety, and pharmacokinetics of giredestrant versus anastrozole (in the…NCT04436744·Burbank, California and 64 others

CompletedDasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid LeukemiaThe primary purpose of this study is to estimate the major cytogenetic response rates of BMS-354825 and imatinib (800 mg/d) in subjects with chronic phase, Philadelphia chromosome…NCT00103844·Birmingham, Alabama and 130 others

CompletedFT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)This is a phase 1 study of FT522 administered with rituximab in participants with relapsed/refractory B-cell lymphoma (R/R BCL).NCT05950334·Orlando, Florida and 6 others

TerminatedPhase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast CancerThis study will assess the safety and efficacy of BKM120 in combination with trastuzumab in patients with relapsing HER2 overexpressing breast cancer who have previously failed…NCT01132664·Birmingham, Alabama and 20 others

CompletedAccess BNP Clinical Enrollment StudyThe goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in…NCT06624293·Loma Linda, California and 16 others

CompletedA Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in PatientsThe purpose of this study is to assess the efficacy and safety of 2 doses of ZACTIMA™ (ZD6474) in combination with FOLFIRI vs FOLFIRI alone for the treatment of colorectal cancer…NCT00454116·Ann Arbor, Michigan and 20 others

RecruitingA Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST.NCT06630234·Scottsdate, Arizona and 9 others

CompletedVitamin D to Improve Outcomes by Leveraging Early TreatmentVitamin D deficiency is a common, potentially reversible contributor to morbidity and mortality among critically ill patients.NCT03096314·Fresno, California and 46 others

CompletedA Study Evaluating the Long-term Safety of VX-445 Combination TherapyThis study evaluated the long-term safety and tolerability of elexacaftor (ELX), tezacaftor (TEZ), and ivacaftor (IVA) triple combination (TC) treatment in participants with…NCT04043806·Birmingham, Alabama and 96 others

CompletedLDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung CancerA single-arm, open-label, two-stage multicenter, phase II study. Patients were pre-screened for ALK positive status.NCT01685138·Boston, Massachusetts and 50 others

CompletedA Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic PouchitisThe purpose of this study is to compare the efficacy of vedolizumab intravenous (IV) and placebo in terms of the percentage of participants with chronic or recurrent pouchitis…NCT02790138·Chicago, Illinois and 33 others

TerminatedSafety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsThis is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion.NCT05275478·Los Angeles, California and 19 others

CompletedPhase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerThis study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have…NCT03906071·Birmingham, Alabama and 260 others

PreviousPage 75 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville